Literature DB >> 7964924

A shape- and chemistry-based docking method and its use in the design of HIV-1 protease inhibitors.

R L DesJarlais1, J S Dixon.   

Abstract

The program DOCK [1,2] has been used successfully to identify molecules which will bind to a specified receptor [3]. The original method ranks molecules based on their shape complementarity to the receptor site and relies on the chemist to bring the appropriate electrostatic or hydrogen bond properties into the molecular skeletons obtained in the search. This is useful when screening a small database of compounds, where it is not likely that molecules with both the correct shape and electrostatic properties will be found. As large databases are more likely to have redundant molecular shapes with a variety of functionality (e.g., members of a congeneric series), it would be useful to have a method which identifies molecules with both the correct shape and functionality. To this end we have modified the DOCK 1.0 method to target user-specified atom types to selected positions in the receptor site. The target sites can be chosen based on structural evidence, calculation or inspection. Targeted-DOCK improves the ability of the DOCK method to find the crystallographically determined binding mode of a ligand. Additionally, targeted-DOCK searches a database of small molecules at 100-1000 times the rate of DOCK 1.0, allowing more molecules to be screened and more sophisticated scoring schemes to be employed. Targeted-DOCK has been used successfully in the design of a novel non-peptide inhibitor of HIV-1 protease.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7964924     DOI: 10.1007/BF00126742

Source DB:  PubMed          Journal:  J Comput Aided Mol Des        ISSN: 0920-654X            Impact factor:   3.686


  26 in total

1.  CLIX: a search algorithm for finding novel ligands capable of binding proteins of known three-dimensional structure.

Authors:  M C Lawrence; P C Davis
Journal:  Proteins       Date:  1992-01

Review 2.  Structure-based strategies for drug design and discovery.

Authors:  I D Kuntz
Journal:  Science       Date:  1992-08-21       Impact factor: 47.728

3.  Automated site-directed drug design using molecular lattices.

Authors:  R A Lewis; D C Roe; C Huang; T E Ferrin; R Langridge; I D Kuntz
Journal:  J Mol Graph       Date:  1992-06

4.  Computer design of bioactive molecules: a method for receptor-based de novo ligand design.

Authors:  J B Moon; W J Howe
Journal:  Proteins       Date:  1991

5.  Functionality maps of binding sites: a multiple copy simultaneous search method.

Authors:  A Miranker; M Karplus
Journal:  Proteins       Date:  1991

6.  Hydroxyethylene isostere inhibitors of human immunodeficiency virus-1 protease: structure-activity analysis using enzyme kinetics, X-ray crystallography, and infected T-cell assays.

Authors:  G B Dreyer; D M Lambert; T D Meek; T J Carr; T A Tomaszek; A V Fernandez; H Bartus; E Cacciavillani; A M Hassell; M Minnich
Journal:  Biochemistry       Date:  1992-07-28       Impact factor: 3.162

7.  Design, activity, and 2.8 A crystal structure of a C2 symmetric inhibitor complexed to HIV-1 protease.

Authors:  J Erickson; D J Neidhart; J VanDrie; D J Kempf; X C Wang; D W Norbeck; J J Plattner; J W Rittenhouse; M Turon; N Wideburg
Journal:  Science       Date:  1990-08-03       Impact factor: 47.728

8.  Hemagglutinins from two influenza virus variants bind to sialic acid derivatives with millimolar dissociation constants: a 500-MHz proton nuclear magnetic resonance study.

Authors:  N K Sauter; M D Bednarski; B A Wurzburg; J E Hanson; G M Whitesides; J J Skehel; D C Wiley
Journal:  Biochemistry       Date:  1989-10-17       Impact factor: 3.162

9.  A symmetric inhibitor binds HIV-1 protease asymmetrically.

Authors:  G B Dreyer; J C Boehm; B Chenera; R L DesJarlais; A M Hassell; T D Meek; T A Tomaszek; M Lewis
Journal:  Biochemistry       Date:  1993-01-26       Impact factor: 3.162

10.  Structure of complex of synthetic HIV-1 protease with a substrate-based inhibitor at 2.3 A resolution.

Authors:  M Miller; J Schneider; B K Sathyanarayana; M V Toth; G R Marshall; L Clawson; L Selk; S B Kent; A Wlodawer
Journal:  Science       Date:  1989-12-01       Impact factor: 47.728

View more
  4 in total

1.  DOCK 4.0: search strategies for automated molecular docking of flexible molecule databases.

Authors:  T J Ewing; S Makino; A G Skillman; I D Kuntz
Journal:  J Comput Aided Mol Des       Date:  2001-05       Impact factor: 3.686

2.  Natural Phytocompounds from Common Indian Spices for Identification of Three Potential Inhibitors of Breast Cancer: A Molecular Modelling Approach.

Authors:  Samik Hazra; Anindya Sundar Ray; Chowdhury Habibur Rahaman
Journal:  Molecules       Date:  2022-10-05       Impact factor: 4.927

3.  Virtual screening of specific insulin-like growth factor 1 receptor (IGF1R) inhibitors from the National Cancer Institute (NCI) molecular database.

Authors:  Cong Fan; Yan-Xin Huang; Yong-Li Bao; Lu-Guo Sun; Yin Wu; Chun-Lei Yu; Yu Zhang; Zhen-Bo Song; Li-Hua Zheng; Ying Sun; Guan-Nan Wang; Yu-Xin Li
Journal:  Int J Mol Sci       Date:  2012-12-14       Impact factor: 5.923

4.  Accurate Prediction of Inhibitor Binding to HIV-1 Protease Using CANDOCK.

Authors:  Zackary Falls; Jonathan Fine; Gaurav Chopra; Ram Samudrala
Journal:  Front Chem       Date:  2022-01-17       Impact factor: 5.221

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.